These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8382584)

  • 41. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
    Van de Casteele M; Hösli M; Sägesser H; Reichen J
    J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis.
    Sansoè G; Aragno M; Mastrocola R; Paternostro C; Parola M
    Clin Sci (Lond); 2013 Jul; 125(2):67-75. PubMed ID: 23384153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.
    Gupta TK; Toruner M; Chung MK; Groszmann RJ
    Hepatology; 1998 Oct; 28(4):926-31. PubMed ID: 9755227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats.
    Xu H; Shi BM; Lu XF; Liang F; Jin X; Wu TH; Xu J
    World J Gastroenterol; 2008 Apr; 14(15):2349-57. PubMed ID: 18416461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in humoral substances in induced cirrhosis and their effects on portal hemodynamics].
    Li XN
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):489-94, 510. PubMed ID: 2575972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).
    Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M
    J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic and hemodynamic responses of bivascularly perfused rat liver to nerve stimulation, noradrenaline, acetylcholine and glucagon in thioacetamide-induced micronodular cirrhosis.
    Zimmermann T; Gardemann A; Machnik G; Dargel R; Jungermann K
    Hepatology; 1992 Mar; 15(3):464-70. PubMed ID: 1544628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
    Wong J; Zhang Y; Lee SS
    J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat.
    Barrowman JA; Granger DN
    Gastroenterology; 1984 Jul; 87(1):165-72. PubMed ID: 6724260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Portal pumping: a new perspective for treatment of variceal hemorrhage and liver failure in end-stage cirrhosis?
    Cardoso JE; el Meteini M; Calmus Y; Vaubourdolle M; Houssin D
    J Hepatol; 1994 May; 20(5):630-5. PubMed ID: 8071539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
    Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
    J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocyte heterogeneity in response to icosanoids. The perivenous scavenger cell hypothesis.
    Häussinger D; Stehle T
    Eur J Biochem; 1988 Aug; 175(2):395-403. PubMed ID: 3165342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethanol-induced vasoconstriction causes focal hepatocellular injury in the isolated perfused rat liver.
    Oshita M; Sato N; Yoshihara H; Takei Y; Hijioka T; Fukui H; Goto M; Matsunaga T; Kashiwagi T; Kawano S
    Hepatology; 1992 Oct; 16(4):1007-13. PubMed ID: 1398480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation.
    Lee CY; Zhang JX; Jones JW; Southard JH; Clemens MG
    Transplantation; 2002 Oct; 74(7):944-51. PubMed ID: 12394835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
    J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.